Venus Concept Inc.

Venus Concept Inc. is a global medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company designs its systems on cost-effective, proprietary, and flexible platforms, allowing expansion beyond traditional aesthetic markets like dermatology and plastic surgery, into non-traditional markets such as family medicine, general practitioners, and aesthetic medical spas. In the years ended December 31, 2024 and 2023, a substantial majority of systems delivered in North America were in non-traditional markets. The company has experienced recurring net operating losses and negative cash flows from operations, with an accumulated deficit of $308.9 million as of December 31, 2024, and $261.9 million as of December 31, 2023. As of December 31, 2024, and December 31, 2023, cash and cash equivalents were $4.3 million and $5.4 million, respectively. Key product trademarks include Venus Viva®, Venus Viva® MD, Venus Legacy®, Venus Concept®, Venus Versa®, Venus Fiore®, Venus Freedom™, Venus Bliss™, Venus Bliss Max™, NeoGraft®, Venus Glow™, ARTAS®, ARTAS iX®, and AI.ME™.